NasdaqCM - Nasdaq Real Time Price USD
Dianthus Therapeutics, Inc. (DNTH)
18.67
-0.17
(-0.90%)
As of 11:04:31 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.53M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MOULDER LEON OLIVER JR. Director | Stock Award(Grant) at price 16.40 per share. | Indirect | 2,733,339 | Jan 22, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 16.40 per share. | Indirect | 13,683,078 | Jan 22, 2024 |
| MENG LEI Director | Stock Award(Grant) at price 16.40 per share. | Indirect | 24,600,000 | Jan 22, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.63 per share. | Indirect | 336,252 | Sep 29, 2023 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.15 per share. | Indirect | 394,500 | Sep 26, 2023 |
| RANDHAWA SIMRAT Officer | Purchase at price 13.20 per share. | Direct | 52,800 | Sep 22, 2023 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.20 per share. | Indirect | 396,000 | Sep 19, 2023 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.69 - 11.76 per share. | Indirect | 120,391 | Sep 13, 2023 |
| THIRD ROCK VENTURES IV, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.82 - 0.83 per share. | Indirect | 3,056,000 | Feb 8, 2023 |
| BEETHAM THOMAS W Officer | Stock Award(Grant) at price 0.94 per share. | Direct | 2,820 | Nov 30, 2022 |
| MAHONEY STEPHEN F Chief Operating Officer | Stock Award(Grant) at price 0.94 per share. | Direct | 2,820 | Nov 30, 2022 |
| GARDNER JASON M PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.94 per share. | Direct | 2,820 | Nov 30, 2022 |
| STANTS KRISTEN Officer | Stock Award(Grant) at price 0.94 per share. | Direct | 2,820 | Nov 30, 2022 |
| DEARDORF CAREN Officer | Stock Award(Grant) at price 0.94 per share. | Direct | 2,820 | Nov 30, 2022 |
| BEETHAM THOMAS W Officer | Stock Award(Grant) at price 0.99 per share. | Direct | 2,970 | May 31, 2022 |
| GARDNER JASON M PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.99 per share. | Direct | 2,970 | May 31, 2022 |
| STANTS KRISTEN Officer | Stock Award(Grant) at price 0.99 per share. | Direct | 2,970 | May 31, 2022 |
| DEARDORF CAREN Officer | Stock Award(Grant) at price 0.99 per share. | Direct | 2,970 | May 31, 2022 |
| BEETHAM THOMAS W Officer | Sale at price 6.73 per share. | Direct | 41,073 | Sep 16, 2021 |
| MAHONEY STEPHEN F Chief Operating Officer | Sale at price 6.73 per share. | Direct | 38,603 | Sep 16, 2021 |
| GARDNER JASON M PH.D. Chief Executive Officer | Sale at price 6.73 per share. | Direct | 96,508 | Sep 16, 2021 |
| STANTS KRISTEN Officer | Sale at price 6.73 per share. | Direct | 38,603 | Sep 16, 2021 |
| OLSON LISA Officer | Sale at price 6.73 per share. | Direct | 38,603 | Sep 16, 2021 |
| NICHOLS DAVID WAYNE Chief Technology Officer | Sale at price 6.73 per share. | Direct | 38,321 | Sep 16, 2021 |
| DEARDORF CAREN Officer | Sale at price 6.73 per share. | Direct | 41,982 | Sep 16, 2021 |
| BEETHAM THOMAS W Officer | -- | Direct | -- | Sep 14, 2021 |
| MAHONEY STEPHEN F Chief Operating Officer | -- | Direct | -- | Sep 14, 2021 |
| GARDNER JASON M PH.D. Chief Executive Officer | -- | Direct | -- | Sep 14, 2021 |
| STANTS KRISTEN Officer | -- | Direct | -- | Sep 14, 2021 |
| OLSON LISA Officer | -- | Direct | -- | Sep 14, 2021 |
| NICHOLS DAVID WAYNE Chief Technology Officer | -- | Direct | -- | Sep 14, 2021 |
| DEARDORF CAREN Officer | -- | Direct | -- | Sep 14, 2021 |
| GARDNER JASON M PH.D. Chief Executive Officer | Sale at price 15.25 per share. | Direct | 170,800 | Jan 10, 2020 |
| GARDNER JASON M PH.D. Chief Executive Officer | Sale at price 15.10 per share. | Direct | 42,280 | Jan 2, 2020 |
| DAVIS JOHN C JR. Officer | Sale at price 15.04 per share. | Direct | 169,817 | Jan 2, 2020 |
| DAVIS JOHN C JR. Officer | Conversion of Exercise of derivative security at price 9.49 per share. | Direct | 107,180 | Jan 2, 2020 |
| ISACSON CHRISTINA K Officer | Sale at price 16.01 per share. | Direct | 71,453 | Dec 24, 2019 |
| ZDRAVESKI ZORAN Officer | Sale at price 16.00 per share. | Direct | 126,432 | Dec 24, 2019 |
| ZDRAVESKI ZORAN Officer | Sale at price 16.00 - 16.03 per share. | Direct | 193,473 | Dec 24, 2019 |
| ZDRAVESKI ZORAN Officer | Conversion of Exercise of derivative security at price 7.71 - 9.49 per share. | Direct | 45,984 | Dec 24, 2019 |
| GARDNER JASON M PH.D. Chief Executive Officer | Sale at price 15.10 per share. | Direct | 43,755 | Dec 23, 2019 |
| ISACSON CHRISTINA K Officer | Sale at price 16.03 per share. | Direct | 158,168 | Dec 23, 2019 |
| ZDRAVESKI ZORAN Officer | Sale at price 16.03 per share. | Direct | 67,021 | Dec 23, 2019 |
| GARDNER JASON M PH.D. Chief Executive Officer | Sale at price 15.16 per share. | Direct | 1,162,617 | Dec 20, 2019 |
| DAVIS JOHN C JR. Officer | Sale at price 15.00 per share. | Direct | 13,785 | Dec 20, 2019 |
| DAVIS JOHN C JR. Officer | Conversion of Exercise of derivative security at price 9.49 per share. | Direct | 8,721 | Dec 20, 2019 |
| GARDNER JASON M PH.D. Chief Executive Officer | Sale at price 15.10 per share. | Direct | 66,319 | Dec 10, 2019 |
| DAVIS JOHN C JR. Officer | Sale at price 15.00 per share. | Direct | 325,035 | Dec 10, 2019 |
| DAVIS JOHN C JR. Officer | Conversion of Exercise of derivative security at price 9.49 per share. | Direct | 205,639 | Dec 10, 2019 |
| COOKE MICHAEL P Officer | Sale at price 12.74 - 13.31 per share. | Direct | 97,520 | Dec 2, 2019 |
Related Tickers
ORKA Oruka Therapeutics, Inc.
9.57
-0.57%
SYRE Spyre Therapeutics, Inc.
14.63
-0.81%
IRON Disc Medicine, Inc.
45.94
-0.88%
VRDN Viridian Therapeutics, Inc.
12.25
-4.41%
ARTV Artiva Biotherapeutics, Inc.
1.9300
-5.85%
NGNE Neurogene Inc.
15.43
-0.52%
ATXS Astria Therapeutics, Inc.
3.9250
+0.64%
ELVN Enliven Therapeutics, Inc.
19.88
-0.77%
CNTA Centessa Pharmaceuticals plc
12.15
-2.49%
CDTX Cidara Therapeutics, Inc.
19.21
-0.77%